Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-21-000006
Filing Date
2021-05-12
Accepted
2021-05-12 13:38:57
Documents
83
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20210331x10q.htm 10-Q 1542031
2 EX-31.1 veru-20210331xex31_1.htm EX-31.1 15763
3 EX-31.2 veru-20210331xex31_2.htm EX-31.2 15988
4 EX-32.1 veru-20210331xex32_1.htm EX-32.1 11765
  Complete submission text file 0000863894-21-000006.txt   7720339

Data Files

Seq Description Document Type Size
5 EX-101.INS veru-20210331.xml EX-101.INS 1825085
6 EX-101.SCH veru-20210331.xsd EX-101.SCH 64894
7 EX-101.CAL veru-20210331_cal.xml EX-101.CAL 74237
8 EX-101.DEF veru-20210331_def.xml EX-101.DEF 204371
9 EX-101.LAB veru-20210331_lab.xml EX-101.LAB 467218
10 EX-101.PRE veru-20210331_pre.xml EX-101.PRE 389204
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 21914565
SIC: 2834 Pharmaceutical Preparations